1. Ung, Dévina C, Pietrancosta, Nicolas, Badillo, Elena Baz, Hepp, Régine, Laumonnier, Frédéric. 2024. GRID1/GluD1 homozygous variants linked to intellectual disability and spastic paraplegia impair mGlu1/5 receptor signaling and excitatory synapses. In Molecular psychiatry, 29, 1205-1215. doi:10.1038/s41380-024-02469-w. https://pubmed.ncbi.nlm.nih.gov/38418578/
2. Guo, Sheng-Zhen, Huang, Ke, Shi, Yong-Yong, Sun, Xiao-Dong, He, Lin. 2007. A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. In Schizophrenia research, 93, 385-90. doi:. https://pubmed.ncbi.nlm.nih.gov/17490860/
3. Treutlein, Jens, Mühleisen, Thomas W, Frank, Josef, Nöthen, Markus M, Rietschel, Marcella. 2009. Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter. In Schizophrenia research, 111, 123-30. doi:10.1016/j.schres.2009.03.011. https://pubmed.ncbi.nlm.nih.gov/19346103/
4. Du, Juan, Liu, Ruyun, Ma, Lin, Cao, Qiuhua, Yu, Jianqiang. 2025. Novel histone deacetylase-5 inhibitor T2943 exerts an anti-depressive effect in mice by enhancing GRID1 expression. In Scientific reports, 15, 4522. doi:10.1038/s41598-025-88670-5. https://pubmed.ncbi.nlm.nih.gov/39915556/